DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Abediterol
Abediterol
Fluticasone Furoate and Vilanterol for the Treatment of Chronic Obstructive Pulmonary Disease
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
15-CLASSIFICATION of DRUG Adrenergic Nonsel Αadr Antag
WO 2014/141069 Al 18 September 2014 (18.09.2014) P O P C T
Download Download
Lääkeaineiden Yleisnimet (INN-Nimet) 21.6.2021
Newer Therapies in COPD
Ultra Labas in COPD
WO 2016/142708 A2 15 September 2016 (15.09.2016) P O P C T
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Newer Bronchodilators
Abediterol, a Novel Long-Acting Β2-Agonist: Bronchodilation, Safety
LABA/LAMA Fixed-Dose Combinations in Patients with COPD: a Systematic Review
Abediterol (LAS100977), a Novel Long-Acting B2-Agonist: Efficacy, Safety and Tolerability in Persistent Asthma J
Ep 2668941 A1
WO 2018/148585 Al 16 August 2018 (16.08.2018) W !P O PCT
Download Paper
Top View
Educational Aims • to Discuss Fundamental Questions Relating to the Use of Bronchodilators That Can Lead to an Optimisation of Their Utilisation
Literature Search Strategy for Treatment of Stable
SIGNIFICANT EVENT Aclidinium Bromide/Formoterol
Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth
Topic: New Treatment = Better Outcome?
Pharmacological Treatment of Chronic Obstructive Pulmonary Disease
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
CURRICULUM VITAE (Maximum 4 Pages)
WO 2016/192680 Al 8 December 2016 (08.12.2016) P O P C T
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
2019 Medicines in Development for Asthma and Allergy
Survival Associated Glioblastoma SNP Candidates
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Spotlight on Fluticasone Furoate/Vilanterol Trifenatate for the Once-Daily Treatment of Asthma: Design, Development and Place in Therapy